Y. Sasaki

Geriatrics and Gerontology · Cell Metabolism · 2004–2016

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom Y. Sasaki trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Imai

Who trusts Y. Sasaki overall

  1. Luis A. Rajman
  2. V. Calabrese
  3. L. Guarente

Papers from Y. Sasaki's perspective

Ordered by how strongly the researchers Y. Sasaki trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Mitonuclear protein imbalance as a conserved longevity mechanism (Nature)
  2. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice (Cell Metabolism)
  3. The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* (Journal of Biological Chemistry)
  4. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. (Cancer Research)
  5. NAD+ metabolism in health and disease.
  6. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. (Cell Metabolism)
  7. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase (Nature)
  8. Metformin as a Tool to Target Aging (Cell Metabolism)
  9. Adipose tissue, inflammation, and cardiovascular disease. (Circulation Research)
  10. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. (Cell Metabolism)

Their papers